Harmony Biosciences Holdings, Inc. (HRMY) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 27.76M | 126.15M | 108.73M | 79.33M | 33.99M | 75.56M | 70.5M | 42.62M | 31.14M | 76.67M | 63.1M | 37.06M |
| Operating CF Margin % | 12.89% | 51.75% | 45.41% | 39.57% | 18.4% | 37.54% | 37.9% | 24.66% | 20.14% | 45.52% | 39.37% | 27.61% |
| Operating CF Growth % | -18.32% | 66.95% | 54.23% | 86.14% | 9.14% | -1.44% | 11.73% | 14.99% | -26.83% | 187.37% | 14.3% | 9.88% |
| Net Income | 32.49M | 22.49M | 50.87M | 39.78M | 45.56M | 49.48M | 46.09M | 11.59M | 38.33M | 26.61M | 38.46M | 34.3M |
| Depreciation & Amortization | 5.97M | 7.43M | 6.13M | 5.97M | 6.13M | 5.97M | 6.14M | 6.23M | 6.3M | 6.13M | 7.36M | 6.49M |
| Stock-Based Compensation | 0 | 10.17M | 10.82M | 11.46M | 12.45M | 10.07M | 11.45M | 10.96M | 10.43M | 8.86M | 7.96M | 7.79M |
| Deferred Taxes | -3.86M | 14.68M | 0 | -6.49M | 0 | -6.71M | 0 | 0 | 0 | 1.12M | 0 | 0 |
| Other Non-Cash Items | 42.8M | -2.65M | 8.81M | 15.11M | -580K | 943K | -17.04M | 34.49M | -6.19M | 2.3M | 2.58M | -4.29M |
| Working Capital Changes | -49.63M | 74.04M | 32.1M | 13.5M | -29.58M | 15.82M | 23.86M | -20.66M | -17.74M | 31.64M | 6.75M | -7.23M |
| Change in Receivables | -11.44M | 3.86M | -7.67M | 12.99M | -22.94M | -1.53M | 1.66M | -3.44M | -5.58M | -6.88M | -3.45M | -11.24M |
| Change in Inventory | 76K | 1.52M | -782K | 284K | 814K | -283K | -1.27M | 214K | -494K | -276K | -233K | -764K |
| Change in Payables | 10.91M | -8.65M | 0 | 10.84M | 0 | 3.21M | 0 | 0 | 0 | 6.2M | 0 | 0 |
| Cash from Investing | -183.65M | -17.63M | -4.79M | -19.59M | 2.36M | -7.19M | 745K | -54.86M | -6.19M | -36.06M | -813K | -7.77M |
| Capital Expenditures | 0 | -19.36M | -71K | -4K | -128K | -513K | -3K | -632K | -5K | -107K | 0 | -205K |
| CapEx % of Revenue | - | 7.94% | 0.03% | 0% | 0.07% | 0.25% | 0% | 0.37% | 0% | 0.06% | - | 0.15% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33.07M | 0 | -44.53M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -32M | 0 | -4.72M | -15M | 2.49M | -1M | 748K | -21.16M | -6.18M | 7.57M | -813K | -7.57M |
| Cash from Financing | -7.22M | -3.02M | -3M | -2.69M | -352K | -2.74M | -1.18M | -3.45M | -3.63M | -53.52M | -55.1M | -339K |
| Debt Issued (Net) | -5M | -5M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -3.75M | -196.5M | -500K |
| Equity Issued (Net) | 347K | 2.65M | 754K | 2.1M | -1.31M | 0 | 0 | -269K | 0 | -50M | -50M | -514K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -55.26M | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -1.31M | 0 | 0 | -269K | 0 | -50M | -50M | -514K |
| Other Financing | -2.56M | -663K | 0 | -1.03M | 4.71M | 1.01M | 2.58M | 573K | 116K | 55.49M | 191.4M | 675K |
| Net Change in Cash | -163.1M | 105.5M | 100.95M | 57.05M | 36M | 65.63M | 70.07M | -15.69M | 21.32M | -12.92M | 7.19M | 28.95M |
| Free Cash Flow | 27.76M | 126.04M | 108.66M | 79.32M | 33.86M | 75.05M | 70.5M | 41.98M | 31.14M | 76.56M | 63.1M | 36.86M |
| FCF Margin % | 12.89% | 51.7% | 45.38% | 39.56% | 18.33% | 37.29% | 37.89% | 24.29% | 20.14% | 45.46% | 39.37% | 27.46% |
| FCF Growth % | -18.01% | 67.95% | 54.14% | 88.93% | 8.75% | -1.97% | 11.72% | 13.91% | -26.84% | 186.97% | 14.48% | 9.4% |
| FCF per Share | 0.47 | 2.15 | 1.85 | 1.36 | 0.58 | 1.29 | 1.21 | 0.73 | 0.54 | 1.30 | 1.04 | 0.61 |
| FCF Conversion (FCF/Net Income) | 0.85x | 5.61x | 2.14x | 1.99x | 0.75x | 1.53x | 1.53x | 3.68x | 0.81x | 2.88x | 1.64x | 1.08x |
| Interest Paid | 0 | 0 | 3.51M | 3.46M | 4.2M | 4.15M | 4.23M | 4.36M | 4.58M | 4.4M | 4.96M | 5.67M |
| Taxes Paid | 0 | 0 | 59K | 35.37M | 0 | 21.09M | 0 | 0 | 0 | 11.69M | 0 | 0 |